The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 22, 2022

Filed:

Sep. 08, 2015
Applicant:

Novartis Ag, Basel, CH;

Inventors:

Shephard Mpofu, Oberwil, CH;

Hanno Richards, Therwil, CH;

Gregory Ligozio, Basking Ridge, NJ (US);

Assignee:

NOVARTIS AG, Basel, CH;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); C07K 16/24 (2006.01); A61K 39/00 (2006.01); C07K 16/18 (2006.01); A61K 45/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/3955 (2013.01); A61K 39/00 (2013.01); C07K 16/18 (2013.01); C07K 16/244 (2013.01); A61K 45/00 (2013.01); A61K 2039/505 (2013.01); A61K 2039/545 (2013.01);
Abstract

The present disclosure relates to methods, uses, medicaments, pharmaceutical formulations, dosage forms, and kits for inhibiting the progression of structural damage in psoriatic arthritis (PsA) patients using Interleukin-17 (IL-17) antagonists, e.g., IL-17 antibodies and antigen-binding fragments thereof, e.g., secukinumab.


Find Patent Forward Citations

Mpofu, Shephard. (2022). Use of il-17 antagonists to inhibit the progression of structural damage in psoriatic arthritis patients (U.S. Patent No. 11278618). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11278618

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…